At Breakthrough T1D Canada, we know that living with type 1 diabetes (T1D) is about far more than managing blood glucose levels. Mental health is critical, and T1D affects a person’s emotional, social, and mental well-being throughout their lifetime. Beyond that, people with T1D are at higher risk of mental health disorders including depression, anxiety and disordered eating. These challenges are common among people with T1D and can be treated — but they are often underappreciated or undertreated because of gaps in care and support. Guided by community input, lived experience, and emerging research, our approach aims to raise awareness, reduce stigma, and expand access to meaningful mental health supports for people living with T1D across Canada.

While much of the public conversation around T1D focuses on children and youth, adults with T1D — the majority of the T1D population — face unique and often underrecognized challenges. From the constant cognitive load of daily decision-making to navigating work, relationships, caregiving responsibilities, and long-term health concerns, adults with T1D carry a significant mental and emotional burden. Feelings of burnout, isolation, anxiety, and diabetes distress are common, yet too often go unspoken or unsupported.

Last year, Breakthrough T1D Canada took an important step forward with the release of a video series on our website highlighting the lived mental health experiences of adults with T1D . The series created space for honest conversations and helped shine a light on stories that deserve to be heard.

Building on this momentum, we are excited to announce a new partnership with You’re Just My Type, a nonprofit dedicated to supporting the mental health of people living with T1D through in-person events, resources, and community-building. You’re Just My Type is unique in its focus on reaching underserved areas by hosting free community gatherings in cities across the United States, creating welcoming spaces where people living with T1D can connect, share, and feel understood — regardless of their differences. These gatherings foster understanding, belonging and resilience, by addressing the mental and emotion weight of diabetes.

This partnership will bring You’re Just My Type to Canada for the first time, recognizing the need for initiatives like this and our shared priorities in the importance of fostering social connection and bonding to improve mental well-being. With a proven track record, we know Canadian adults living with T1D will love the in-person and virtual opportunities to take part in these initiatives! Laura Pavlakovich, founder of You’re Just My Type and a person living with T1D was inspired to create the organization. Having lived with the condition for nearly her entire life, she found that the mental toll can often be heavier than the physical.

Laura’s background is in photojournalism, a path that took her all over the world and ignited her passion for storytelling and human connection. In 2016, she began combining these two worlds — photography and T1D — to share the stories of the T1D community. That work eventually grew into You’re Just My Type, where they now focus on building mental-health-centered, peer-led spaces for those living with this condition.

Looking ahead, Breakthrough T1D will be hosting free, in-person mental health events for adults with T1D, taking place in Vancouver on Saturday May 30, in Toronto later this year, and an online event in the fall. Follow Breakthrough T1D Canada and You’re Just My Type on social media for registration details and updates.

Together, we’re working to ensure no one faces the mental health challenges of T1D alone.

The post Supporting mental health in adults living with type 1 diabetes appeared first on Breakthrough T1D.

UPDATE: March, 2026 

Two new Phase 3 clinical trials to study the efficacy of baricitinib as a disease-modifying therapy for T1D. 

Baricitinib is a JAK inhibitor that interferes with signaling pathways critical to both immune cells and beta cells. This drug has the potential to extend the “honeymoon period” of T1D, meaning that it could preserve remaining insulin-producing beta cells earlier in disease progression. More beta cells mean better blood sugar management—and potentially reduced long-term complications. 

Following very promising results from a Breakthrough T1D-funded Phase 2 study of baricitinib in newly diagnosed individuals with T1D in Australia (see full study write up and results below), Eli Lilly and Company are now launching two new Phase 3 clinical trials. These new international trials will include locations in Canada – click the links below to find out where the studies are recruiting: 

BARICADE-DELAY 

• Purpose: To determine if baricitinib can delay the onset of clinical stage 3 T1D in people who are at high risk 

• Eligibility: Must be between one and 36 years old and be in stage 2 T1D 

• Primary outcome: Time to diagnosis of stage 3 T1D 

BARICADE-PRESERVE 

• Purpose: To determine if baricitinib can preserve beta cell function in people with newly diagnosed T1D 

• Eligibility: Must be between one and 36 years old and diagnosed with stage 3 T1D within the last 100 days 

• Primary endpoint: C-peptide preservation (a measure of insulin production) 

To learn more about the trial and eligibility: Breakthrough T1D – Clinical Trials

***

Insulin, administered either by pump or multiple daily injection, remains the only available treatment for type 1 diabetes (T1D). Breakthrough T1D is aiming to change that and move beyond insulin by accelerating the development of medicines that prevent, delay, or reverse T1D by targeting the autoimmune response, beta cells, or both. Supporting studies that explore how drugs may preserve beta cell function is key to our disease-modifying therapies portfolio.

In a Breakthrough T1D-funded clinical trial, published in the renowned New England Journal of Medicine , Thomas Kay, M.B.B.S., Helen Thomas, Ph.D., and others demonstrated that baricitinib—a small molecule that blocks Janus Kinase, which is critical to signaling pathways within both immune cells and beta cells in T1D—preserved beta cell function in the disease.

The BANDIT study investigated the use of baricitinib, a treatment already approved by Health Canada for other autoimmune diseases like rheumatoid arthritis, in newly diagnosed T1D individuals. This JDRF-funded study was funded by JDRF and JDRF Australia and conducted at St. Vincent’s Institute of Medical Research in Australia. The study was conducted after years of research by Thomas Kay and others, as well as important work by JDRF advocating for Eli Lilly to provide the baricitinib for the study.

Study Overview

• Participants were between 10 and 30 years old and began taking baricitinib within 100 days of diagnosis
• Participants either received baricitinib or a placebo drug
• The study ran for 48 weeks, and results were analyzed at 12, 24, 36 and 48 weeks
• The primary outcome was average C-peptide (a measure of how much insulin is still being made by a person’s own beta cells) following a standard meal at week 48
• Secondary outcomes were HbA1c (average glucose level over a 2–3-month period), insulin use, and continuous glucose monitor (CGM) measures

Results

In 60 newly diagnosed children and young adults, baricitinib:

• Preserved insulin production, as estimated by C-peptide
• Improved blood-glucose variability (blood glucose levels were more stable) and time-in-range (the percentage of your day within your set blood glucose targets), using a CGM
• Decreased the requirement for external insulin
• Was well-tolerated by the participants

The effect of baricitinib was achieved using a single daily oral tablet, and it’s the first immunotherapy trial to suggest a benefit on CGM measures. (Verapamil, a once-a-day tablet approved for blood pressure management , also preserved beta cell function, but without improvement in CGM measures or insulin requirement.)

What comes next?

Currently, baricitinib is approved for the treatment of rheumatoid arthritis in adults in Canada. It is not however a Health Canada approved therapy for people with T1D. Breakthrough T1D has multiple lines of inquiry to make sure that this and other disease-modifying drugs get to the hands of people with T1D . There are several clinical trials that Breakthrough T1D is exploring to see if baricitinib can be effective if used in conjunction with other therapies, such as Tzield (teplizumab-mzwv) or verapamil.

What does this mean for people with T1D?

These promising results show that this drug can extend the honeymoon period (the phase in early type 1 diabetes development where the body is still producing some of its own insulin), but more studies are needed before it can become available to the T1D community. As this drug is already approved for use in rheumatoid arthritis (RA) in Canada, the path to its potential use in T1D may be more rapid. Studies that explore the use of disease-modifying drugs, such as baricitinib orustekinumab, in another Breakthrough T1D-funded trial currently recruiting in Canada, are key to helping Breakthrough T1D address the autoimmunity behind T1D.

This treatment is not currently available in Canada for people with T1D, but Breakthrough T1D Canada will share further updates and results as they become available.

The post Update on clinical trials to study the efficacy of baricitinib as a disease-modifying therapy for T1D appeared first on Breakthrough T1D.

On Jan 7, 2025 (Sweden), Sana Biotechnology released significant clinical data: the first person with type 1 diabetes (T1D) who received deceased donor islets engineered to evade the immune system is producing insulin without immunosuppression.

UPDATE: March, 2026

At the Advanced Technologies & Treatment for Diabetes international conference held in Barcelona, Spain Per-Ola Carlsson, M.D., Ph.D., presented updated results from a Sana’s clinical trial involving a novel cell therapy approach designed to help transplanted islet cells evade immune attack via gene editing while continuing to produce insulin.

 After 60 weeks, the single participant has reported no severe or unexpected adverse events, meeting the trial’s primary safety endpoint. At 14 months after transplantation, the participant continued to produce detectable C-peptide, indicating that the transplanted cells remained alive and functional.

Researchers also observed that C-peptide levels temporarily declined after about one year, likely due to beta cell exhaustion, but subsequently recovered. This is an encouraging signal that the transplanted cells may be capable of regaining function.

While still very early, these findings provide important proof of concept that gene-edited, immune-evasive islet cells can survive and function in a person with T1D. If confirmed in larger studies, this approach could help move the field closer to cell therapies that work without long-term immune suppression—a major goal for the future of T1D cures.

UPDATE: June 23, 2025
Sana Biotechnology presented updated data on June 23, 2025 at the six-month follow up timepoint. The single patient dosed with hypoimmune donor islets continues to produce insulin in response to a mixed meal tolerance test (MMTT) without the use of immunosuppressants. 

The details

This is a big step for cell-based therapies for potentially curing T1D. Sana’s first-in-human study consists of allogeneic islets, meaning they are derived from an external source, which in this case is the pancreases of deceased donors. These islets were engineered to avoid recognition by the immune system (hypoimmune) and were implanted intramuscularly into a person with T1D. After four weeks, circulating C-peptide increased, meaning that the beta cells are alive, healthy, and producing insulin—all without the need for immunosuppression and no safety issue. This is the first evidence of engineered islets successfully avoiding immune destruction.

What this means for the T1D community

While this is an incredibly promising step forward for the T1D community, to have allogenic cells survive without the use of immunosuppressants, this trial relied on deceased donor cells, of which there will never be enough to provide to everyone living with T1D.  The trial was done in a single participant and is reporting only 4-weeks of data – this is a proof-of-concept study that is promising but very preliminary.

What’s next: lots to look forward to

Breakthrough T1D believes that the best chance for T1D cures lies in stem cell-based therapies since deceased donor islets are in short supply, while stem cell-derived islets can be produced at scale. Engineering cells to evade immune attack is a new path forward to protect the insulin-producing beta cells and avoid the use of immunosuppressants. Most importantly, this technology is being studied to apply to stem cell-based therapies, which is a scalable solution for many more people with T1D. This hypoimmune technology moves us closer to the possibility of having enough immune-evading cells for everyone with T1D.

Another trial is in progress testing a similar approach (CRISPR) in Canada – https://clinicaltrials.breakthrought1d.ca/clinical-trial/NCT05565248

While this approach will take significant time, effort, and money, every day we take another step toward a possible life-changing T1D cure. 

Breakthrough T1D’s Role

The primary objective of Breakthrough T1D’s beta cell replacement efforts is to place insulin-producing cells into people with T1D without the use of immunosuppressants. Breakthrough T1D strongly supports the development of stem cell-based therapies that do not require broad immunosuppression and Breakthrough T1D International based out of the US recently launched an initiative to accelerate this faster than ever (Project ACT – Accelerate Cell Therapies). To contribute to the advancement of these game-changing therapies, the T1D Fund: A Breakthrough T1D Venture invested in Sana recognizing that their hypoimmune engineering technology held significant promise for T1D cell therapies. We look forward to seeing how the trial progresses.

The post Cell therapy first: transplanted islets working without immuno-suppressives appeared first on Breakthrough T1D.

From left to right: Breakthrough T1D Canada staff members Lara Green and Lauren Germain, along with Justice Maki-Chambers and Roslynn Baird, Client Services Administrator, and Godrihwasido (Cayuga “Overseer”), Executive Director of IDHC respectively.

Breakthrough T1D Canada is partnering through a community grant to the Indigenous Diabetes Health Circle (IDHC) to help to address an unmet need with Canada’s Indigenous T1D community.

The grant will help support the development of community informed resources for Indigenous Canadians living with T1D.

Breakthrough T1D had the opportunity to speak with Justice Maki-Chambers, the lead on the project about how it came about and will roll out to improve support and health outcomes for Canada’s Indigenous T1D communities.

Tell us a little bit more about yourself

My name is Justice Maki-Chambers, and I’ve been working as an Eye Health Lead at IDHC for about 3 years. Our Eye Health program focuses on culturally informed approaches to diabetic retinopathy screening in Indigenous communities, in partnership with Vision Loss Rehabilitation Canada (VLRC). On a personal note, I was diagnosed with T1D when I was 16 years old, nearly 10 years ago. Like it is for most people, it was a hard adjustment. This shaped my passion for diabetes education and community-centered health education. Much of my work is grounded in building relationships, supporting self-determination in health, and making sure people have access to the tools they need to stay well.

How did you get involved with IDHC?

When I was working through my Public Health degree at Brock University, I frequently passed IDHC’s head office on my way to and from campus. I had remembered thinking “I am going to work there one day”. Years later, when I was nearing the end of my degree and needed a practicum, I reached out to see if there was any work I could do. Luckily for me, there was. This grew into a contract position within the Client Services Team, and then to a permanent position working on the Eye Health Screening Initiative. IDHC’s commitment to diabetes prevention and management, holistic wellness, and culturally grounded health education is something I’ve admired for a long time, and I am proud to now be a part of.  It’s been humbling to contribute to a space where everyone works so tirelessly to uplift Indigenous wellness and create meaningful, lasting change.

Tell us a little bit more about how the IDHC plans to use the community grant to forward the needs of Indigenous diabetes communities in Canada

IDHC has plenty of resources regarding type 2 diabetes, pre-diabetes and gestational diabetes. While these resources can still be beneficial for people living with T1D, there are still important differences to consider, and we would like to support Indigenous individuals living with T1D in the same capacity. We have also had an influx in requests for T1D specific education due to a higher rate of T1D diagnoses in the past few years. 

With this community grant, we have developed a Committee of Indigenous people with lived and loved experience to guide the project. We have been doing call outs to have others who live with T1D or are a caregiver of someone who has T1D be interviewed by our committee to hear what kind of resources are actually going to be useful. Once the interviews and surveys are complete, we will use them as a guide to create said resource. Ultimately, we are hoping to create a culturally grounded, accessible and practical and community-informed resource to better support Indigenous people and families living with T1D.

Any further message you want to share with the Canadian T1D community?

As we all know, living with T1D means constantly adapting, learning, and advocating for yourself and others in the T1D community, and this dedication does not go unnoticed. Everyone’s journey with T1D is a little different, but at the end of the day, we all deserve care that respects who we are, where we come from, and the strengths we carry. We deserve access, understanding, and resources that shift with us through our journeys. Chi Miigwech (Thank you) to everyone who has lived with diabetes and has fought for these resources and advancements to make our lives better and thank you to everyone who comes after us to continue this important work.

Surveys to help inform the development of these new materials and resources are available below:

Survey for Indigenous people living with T1D and their caregivers 

 https://soadi.wufoo.com/forms/s1nee8th050bbl5/ 
 
Survey for community health workers and healthcare providers with Indigenous patients living with T1D 

https://soadi.wufoo.com/forms/swkly7c1wvmhaz/

The post New partnership will connect Indigenous Canadians with type 1 diabetes to necessary resources and support appeared first on Breakthrough T1D.

Danica Doble, a fitness coach and content creator who has been living with type 1 diabetes (T1D) since 2009 recently partnered with Breakthrough T1D Canada as a social media ambassador. She sat down with the organization to share more about her journey, and why she’s so open about how teenage struggles living with T1D empowered her to become a fitness trainer and passionate advocate for the T1D community.

Content warning: please note this piece discusses eating disorders

What do you remember about your T1D diagnosis?

I remember being a seven-year-old little girl and experiencing all of the vicious symptoms that come along with a type 1 diabetes diagnosis. It was a Monday night, and I was at gymnastics practice. Immediately after practice, my mom got a phone call from my doctor stating that I needed to go to the hospital because I had just been diagnosed with T1D. For the next five days, I spent eight hours in the hospital each day and my parents learned everything they could about T1D. Back in 2009, type one diabetes wasn’t talked about much, so my parents really didn’t know what to expect. I remember playing with all the toys that they provided in the hospital and thank goodness for my parents for being attentive, because I most definitely was not. I returned to normal life after those five days, not knowing what was happening to me, not knowing why my parents had to poke my finger and poke my arm every time I wanted to eat. However, as hard as that week was, that week is the reason that I’m who I am today.

Can you tell us a little about starting your fitness journey, after being an active teenager with T1D?

My fitness journey began in 2018; I was like every other teenager. I played sports. I hung out with my friends. I went to school. To be honest with you, I probably lived too much of a normal life. I neglected my blood sugars throughout my teen years and was definitely not focussed on diabetes management. I partied a little too much at times and had a little too much fun with my friends, however, I definitely don’t regret anything because not only did I experience life, but it also prompted me to start my fitness journey.

Although I was quite active as a competitive soccer player, my nutrition was really something that I neglected. After my trip to Europe in 2018, I had told myself that I just wanted to lose 5 pounds to feel better about myself. I quickly learned about calorie deficits and strength training and began doing things to an extreme. 5 pounds later turned into 50. During this time, I had not only lost too much weight but had also lost my period and had developed two eating disorders. It was at this point that I decided to become the healthiest and strongest version of myself. I put on about 20 to 30 pounds, much of it being muscle, and learned everything you could about working out and nutrition.

Can you share a little about your dual diagnoses and how you manage your binge eating disorder (BED) today

My binge eating lasted for about two years, and it was due to the fact that I had eaten so few calories for so long. There were many days when I felt so out of control with my eating and I would compensate these binges by doing hours worth of cardio the next day. It’s an incredibly vicious cycle and very, very difficult to get out of. After my binges, my blood sugars would be so incredibly high, and it would take them hours if not days to come down then the cycle would repeat itself. Today, I am proud to say that I have been free for five years. I started fueling my body properly and made sure that I was getting enough calories. Although I still struggle at times with overeating I no longer eat until I feel sick, which in my opinion is major progress.

How did you come to have food neutrality?
My relationship with food has been rocky over the years, but I am proud to say that my relationship with food is at an all-time high. I now understand that there are no good or bad foods and food is food. Some foods are more nutrient dense while other foods are less nutrient dense. However, that does not make one better over the other. Sometimes my body craves a chocolate cake while other times my body is craving a bowl of fruit. In my opinion, I believe that all food serves a significant purpose whether it’s food that makes your body feel good, or food that makes your soul feel good. While the way I physically feel matters, so do memories. I’ve come to realize that food will always be a massive part of celebrations and events, and when I’m 80 years old, I want to be able to look back on these memories and remember all of the laughs that were shared over good food, not how little I ate that day or how healthy I was during these events.

How does powerlifting help you feel empowered with managing your T1D, both physically and emotionally?

Weightlifting has done wonders for me not just physically, but emotionally too. Not only has it significantly helped my blood sugars, but it helped me in so many other aspects of my life. The empowerment I feel from weightlifting is like no other because it just really goes to show that you can do absolutely anything in your life, even with type 1 diabetes.

How do you use your social media platforms to connect with others in the T1D community

I started my social media platforms in 2022 to mainly focus on the fitness side of things however, after about a year, I wanted to do more. I wanted to make an impact for the T1D community and show people that living with it can have positives. I started my type one diabetes account by posting relatable content and bringing light to dark topics quickly. I was able to grow a substantial following on that account and created a community like no other! I’ve connected with hundreds, if not, thousands of people and it is something I will forever be grateful for. I get tons of messages from people telling me that I’ve helped them, when in reality they’ve helped me just as much.

What are you excited about partnering with Breakthrough T1D Canada?

I’m excited to partner with Breakthrough T1D Canada because of the incredible impact the organization has on the type 1 community. I believe that it’s so important to hear stories and experiences from other type 1s, so people know they’re not alone in their experience & journey.

Anything else you’d like to share with the Canadian T1D community?

I’d like to share with the community that as much as diabetes can suck sometimes, and be incredibly difficult, perspective is everything. Type 1 diabetes has connected me with so many amazing people, and it’s made me strong, courageous, and powerful!

Follow Danica on her IG account @deeabetes

The post Finding her strength: Fitness coach Danica Doble shares in her own words appeared first on Breakthrough T1D.

Sunday, March 8 is International Women’s Day (IWD), celebrated globally and this year recognizing its 115 anniversary. On IWD we are asked to imagine a world that is truly equal. For that to happen, we need a world free of bias, stereotypes, and discrimination. A world that’s diverse, equitable, and inclusive. A world where difference is not only recognized but also valued and celebrated. 

The theme for IWD 2026 is ‘Give To Gain’.  Because, when we give, we gain. 

The IWD 2026 Give To Gain Campaign encourages a mindset of generosity and collaboration and emphasizes the power of reciprocity and support. When people, organizations, and communities give generously, opportunities and support for women increase. Giving is not a subtraction, it’s intentional multiplication. When women thrive, we all rise. 

This theme resonates deeply with Breakthrough T1D Canada, an organization with humble grassroots beginnings, started in the basement of type 1 diabetes (T1D) families desperate to find a cure for their children, but also to raise awareness of what living with this disease is truly like. 

From our beginning, we have both supported women, but even more, have been supported by women. From the mothers who demanded more for their children, and their daughters who became some of the T1D community’s fiercest advocates, and who continue to do so today.  

To our researchers, many of whom are women, and who continue down the path laid by trailblazing women like Dr. Priscilla White, who was an early pioneer in diabetes research and treatment. Dr. Dorothy C. Hodgkin who first discovered the three-dimensional structure of insulin, Dr. Helen M. Free, who along with her husband created Clinistix, allowing people to check their glucose at home, a significant advance in disease management.  

These women played an essential role in advancing understanding of T1D, and the dozens of women researchers we are proud to support today continue this legacy, leading their own critical projects that improve living with T1D and driving us closer to cures. Women researchers can be found in all areas of T1D research, including precision medicine, cell therapy, screening and prevention, disease-modifying therapies, reproductive health and mental health. 

Breakthrough T1D also supports a number of women fellows and post-docs, who are leading the next generation of researchers in all areas of T1D research.   

To our donors, supporters, volunteers and partners who give tirelessly and selflessly so that these researchers can continue their critical work and get us closer to a world free from T1D. Who with all they give, allow other women to thrive in their field and gain the knowledge needed to make living with T1D safer and better today, while they work towards cures for tomorrow. 

To our women-led organization, who are entrusted with the responsibility of stewarding that support with consideration and care.  

We have come a long way since the first International Women’s Day 115 years ago, but there is still so much more work to be done. Breakthrough T1D Canada renews our commitment to ‘Give To Gain’ and continue the important work of creating a gender equal world.

The post Give to Gain this International Women’s Day  appeared first on Breakthrough T1D.

CIRTN was established in 2020 as a world-class training and research network with joint contributions from the University of Alberta, University of British Columbia, University of Manitoba, Université de Montréal, Institut de Recherches Cliniques de Montréal, and the University of Toronto and now includes 12 institutions from across Canada.   

Breakthrough T1D Canada has partnered with CIRTN to leverage funding to this network from the National Science and Engineering Research Council – Collaborative Research and Training Experience (NSERC-CREATE) program.  

Previous cohorts: 

2023 

2024 

2025 

Dr. Austin Miller –Postdoctoral Fellow (supervisor: Francis Lynn, University of British Columbia) 
Improving the ability to generate stem cell-derived pancreatic islets in the lab 
Regenerative medicine approaches are being developed as an alternative in which pancreatic islets are transplanted into patients to restore autonomous insulin secretion, reducing the patient burden of T1D management. Stem cell-derived pancreatic islets (stem cell islets) have the potential to provide an unlimited supply of islets for transplantation.  

Overall, my research aims to improve our ability to generate stem cell-derived islets in the lab. I will develop tools to study cellular pathways that allow cells to manage the burden of secreting proteins like insulin and perform studies to better understand the role of these pathways in the generation of insulin-secreting cells. These findings will inform strategies to further improve the efficiency of stem cell-derived islet generation. 

Dr. Chris Schaaf – Postdoctoral Fellow (supervisor: Patrick MacDonald, University of Alberta)  
Standardizing stem cell-derived beta cells 
The advent of stem cells has provided a promising approach towards generating a functional cure for type 1 diabetes. However, current protocols do not generate stem cell-derived beta cells that appropriately produce and regulate insulin secretion, and there is a lack of standardized assays, benchmarks, and analytical tools for comparing stem cell-derived beta cells to human donor islets. 

This project will leverage the humanislets.com dataset – a collection of ‘gold standard’ molecular and functional datasets from hundreds of human organ donors – funded by Breakthrough T1D and CIHR.  Using this robust dataset and collaborative expertise in computation and artificial intelligence, we will perform comparative analyses and benchmarking for the improvement of stem cell-derived beta cell outcomes. This will enable us to develop benchmarking standards and protocols that can be used by researchers anywhere in the world to compare their own lab generated  stem cell-derived beta cells to our repository of human donor islets data, and use that data to generate  stem cell-derived beta cells that truly mimic the function of human beta cells. 

Yihan Luo – PhD student (supervisor: Kacey Prentice, University of Toronto)  
A new approach to prevent type 1 diabetes by strengthening insulin producing cells 
In the human body, organs communicate with each other through hormones, such as insulin, made by beta cells in the pancreas. Insulin tells fat, muscle, and liver cells to absorb sugar from the blood, which provides energy and keeps blood sugar levels in balance. In type 1 diabetes (T1D), the immune system destroys beta cells, causing lifelong insulin deficiency. Evidence suggests that T1D begins before beta cell loss, due to disrupted insulin responses and organ–pancreas communication. Fabkin, a hormone complex secreted by fat, affects beta cell health and research has shown that blocking it in mice helped beta cells stay healthier. Our project studies Fabkin’s key component, NDPK, to learn how it affects beta cell survival and function, and test whether NDPK-targeting drugs can prevent or delay T1D. If successful, this work could lay the foundation for a new approach to prevent T1D by protecting beta cells before they are damaged or lost. 

The post Breakthrough T1D Canada is pleased to announce three new trainees in partnership with the Canadian Islet Research and Training Network  appeared first on Breakthrough T1D.

Stephanie Atkinson, a Montreal, QC based adult Breakthrough T1D Canada ambassador, sat down with the organization to discuss what drew her to volunteering and what it’s like to be diagnosed as a busy mother and businesswoman.

Tell us a little bit more about yourself

My name is Stephanie Atkinson. I’m a mom of four, a skin and beauty expert, founder of Mayfield Glow, and a recent finalist on the Miss Universe Canada stage.

Before anything else, I’m someone who has learned firsthand how fragile life can be — and how powerful resilience is.

I built my career helping women feel confident and cared for through skincare and wellness. But my own health journey shifted my purpose in a deeper way.

Standing on the Miss Universe Canada stage as one of the first finalists openly wearing two visible diabetes devices — an insulin pump and a continuous glucose monitor — wasn’t just about competing. It was about representation. It was about showing that living with a chronic illness does not disqualify you from showing up fully, boldly, and beautifully in the world.

Today, I use my platform to advocate for type 1 diabetes awareness, especially for adults diagnosed later in life, while balancing motherhood, entrepreneurship, and advocacy.

Can you share a little bit about your diagnosis? What do you remember?

Before my diagnosis, I was sick for many days, but it was during COVID and most clinics were closed, so accessing care felt nearly impossible. I was exhausted in a way that didn’t make sense. I now know I was experiencing all the classic “4 Ts” of type 1 diabetes — thirst, tiredness, toilet, and thinner. I was constantly thirsty, extremely fatigued, using the bathroom nonstop, and losing weight rapidly. My vision began to blur, I could barely walk, and deep down I knew something was very wrong — but as a mom, you push through.

When I finally got into a clinic, I was told I had a urinary tract infection. I remember saying I had never had one before, but I was told that strange things happen before turning 30. I left feeling dismissed, even though my body was telling me something much more serious was happening.

The next morning, everything changed.

I woke up to a police officer at my door doing a wellness check. My doctor had reviewed my results and realized I had been misdiagnosed — my blood work showed I was actually in diabetic ketoacidosis (DKA), a life-threatening emergency where the body begins breaking down fat for fuel because it cannot use glucose properly without insulin. Acid builds up in the bloodstream, and without immediate treatment, it can be fatal.

When I got to the hospital, things were still confusing. Initially, I was diagnosed with type 2 diabetes because I was an adult. But my condition worsened quickly, and I ended up in the ICU with severe DKA. I remember feeling like my body was shutting down. I was losing vision in my left eye, I couldn’t walk properly, and everything felt overwhelming and terrifying.

Later, after further testing, I was correctly diagnosed with type 1 diabetes.

I was 29 years old, a mother, and suddenly my entire life changed. I didn’t fit the stereotype people imagine when they think of Type 1 diabetes — and that experience is one of the main reasons I advocate so strongly today, especially for adults who are diagnosed later in life.

Over 70% of Canadian T1D diagnoses are in adults. How did you find the transition to your new normal?

The hardest part wasn’t just learning how to manage insulin — it was realizing how little support exists for adults diagnosed later in life. 

As a mother and entrepreneur, I had to quickly learn how to balance blood sugars, medical appointments, and new technology while still showing up for my family and my work. There’s a lot of education and community built around children diagnosed with Type 1, but adult diagnosis can feel isolating.

To be honest, there were many times I wished I had been diagnosed as a child. By the time I was diagnosed, I was already an adult, already a mom, already carrying so many responsibilities. A lot of guilt came with that — guilt about how my diagnosis might affect my family, guilt about slowing down, and guilt about having to suddenly prioritize my health in ways I never had before.

Over time, I learned that managing diabetes isn’t selfish — it’s necessary. I built a support system, connected with community, and learned to use technology as a tool for confidence instead of fear. That transition taught me how strong and adaptable we really are, and that being diagnosed later in life doesn’t mean you’re behind — it just means your journey looks different.

You went into DKA prior to your diagnosis. Are ketone levels and how they’re measured something you think about more now?

Absolutely. Once you’ve experienced DKA, awareness becomes second nature.

I pay close attention to how my body feels, especially when blood sugars are elevated or when I’m sick. I monitor ketones when needed and rely heavily on my diabetes technology for early warnings. It’s not about living in fear — it’s about understanding my body and staying proactive so I can avoid going through that experience again.

Why do you wear your diabetes devices so visibly?

The honest answer is that at first, I didn’t want to.

In the beginning, I was ashamed of my devices and tried to hide them as much as possible. As a woman working in beauty and wellness, I felt pressure to look polished and seamless, and I worried that people would only see my diagnosis instead of me.

What changed my perspective was my children.

One day, one of my kids came home from school excitedly telling me about a student in their fifth-grade class who wore a Dexcom and was having a diabetic emergency. Because my child was familiar with diabetes from watching me manage it every day, they recognized what was happening and were able to help alert an adult quickly.

That moment shifted something in me. I realized this was bigger than me. If more people saw these devices visibly — and understood what they were — it wouldn’t just help me feel more confident, it could help others too.

On the Miss Universe Canada stage, I made a conscious decision not only to wear my devices openly, but to bedazzle them. So many times, I hear, “But you don’t look sick.” And the truth is — Type 1 diabetes is an invisible illness. I wanted to bring joy and light to something that can feel heavy and misunderstood. If I was going to wear them, I was going to wear them proudly.

Visibility creates conversation. Conversation creates understanding. And understanding saves lives.

If someone sees me and feels less alone or more confident wearing their own devices, that makes it all worth it.

Is there anything else you wanted to share with the T1D community, particularly with others diagnosed as adults?

You did not cause this.

Being diagnosed as an adult can feel confusing and isolating because many people still believe type 1 diabetes only happens in childhood. When you’re diagnosed later in life, you’re often already carrying so many responsibilities — careers, families, and expectations — and it can feel like your world shifts overnight.

But your diagnosis does not change your value, your strength, or your future.

Give yourself permission to learn slowly, to ask for help, and to prioritize your health without guilt. Managing diabetes isn’t about being perfect — it’s about showing yourself grace and continuing to move forward. 

You can still chase your dreams. You can still show up boldly. You can still build a beautiful, full life. Type 1 diabetes is something I manage — it does not define or limit who I am.

***

Breakthrough T1D Canada thanks Stephanie for her efforts on behalf of the T1D community and for her important work as a peer support volunteer and advocate.

The post In her own words: Stephanie Atkinson appeared first on Breakthrough T1D.

What does a cure for type 1 diabetes (T1D) look like?

Authors: Katie Bartel, Beth Miller, Tony Lucas, Benjamin Mammon, for The Breakthrough T1D Canucks For Kids Fund Centre of Excellence at UBC T1D Lived Advisory Group

That was the question that the Type 1 Diabetes Lived Experience Advisory Group attempted to answer through a recent anonymous survey.

The group quickly learned it’s not an easy puzzle to solve.

The Breakthrough T1D Canucks For Kids Fund Centre of Excellence at UBC T1D Lived Advisory Group has a key role at Centre outreach events and enabling dialogue between researchers and people living with T1D. The recent survey was done to gather information to inform these discussions and, in turn, the Centre’s cure-focused research program.

Of the 49 respondents, there were varying degrees of what a cure for T1D looks like – some want fully functioning insulin production, whereas others would be satisfied with a device-free lifestyle. Some respondents focused more on improved quality of life, while others struggled to put any kind of description to a T1D cure.

“Type 1 requires so much decision making on a daily basis that I cannot help but wonder what my brain will do with that space and time,” one participant commented. “Am I less likely to face decision fatigue? More likely to have more resilience to frustration… the potential is significant, but the ability to guess what that might be is difficult.”

It’s these types of responses that the Centre’s T1D Advisory Group believes is essential for researchers to know.

“If we don’t know what a cure looks like for people with type 1 diabetes, we can’t work towards it,” said Dr. Søs Skovsø, scientific project coordinator at the Centre, and Chair of the Advisory Group.

And that’s where the Advisory Group plays a role.

The Advisory Group is made up of eight members who either live with T1D or care for people living with T1D. The group’s objective is to integrate the voices of people with T1D into T1D research.

The Advisory Group developed a survey that was distributed through local T1D community networks and stayed open for one month. There were 49 respondents in total; 33% were caregivers and 67% lived with T1D. Most respondents lived in Canada – 53% in BC and 41% in other provinces. The remaining 6% lived internationally.

The main query of the survey was “What does a cure for T1D mean for you?”

Questions included rating the importance of restoring the body’s ability to produce its own insulin again, versus preventing the immune system from attacking insulin-producing cells. The survey asked about the importance of a cure being device free, as well as the significance of improvements to quality of life gained with the introduction of a cure.

51% of survey respondents responded that a cure involving stem cell therapy would be extremely important; 58% rated immune therapy as extremely important; and 40% rated being device-free as extremely important. And when asked about the most important benefit that a T1D cure could provide – improved mental health was rated higher than freedom from blood sugar checks, elimination of insulin dependence, and reduction of long-term health risks.

The question that was most surprising for Advisory Group members and researchers at the Centre was how confident respondents were that a cure would be found in their lifetime.

Responses varied: some were confident, others skeptical.

“The mixed response from the community doesn’t reflect the exciting work that’s going on at the Centre,” said Advisory Group member Beth Miller. “This highlights a need for better communication between the scientific community and the broader T1D community,” Miller added.

Skovsø agrees.

“Some people have lost hope for a cure, and at the same time others thinking that there’s a cure coming next year,” she said. “This means that the research community has to do a better job at communicating that a cure may not be available next year, but it is within reach.”

The Advisory Group’s survey is the first of its kind according to Dr. Bruce Verchere, one of the lead principal investigators at the Centre.

“This survey promises to increase the impact of T1D research in the Centre by helping researchers better understand the hopes and expectations of persons living with T1D, and how research could improve their lives,” said Verchere.

“What a cure looks like to a parent of a child with T1D, or to someone living with T1D for 30 years, or to a scientist is going to be different,” said Skovsø. “Hopefully this survey will help open minds that a cure is not single-sided; it’s multi-faceted.”

This survey was just the first step. A second quantitative survey is now being developed by the Advisory Group, in collaboration with the Centre research team, with the intent of reaching a wider audience and publishing the results in a scientific journal.

“It’s cool to see the work and conversations coming out of the Advisory Group trickle and spread into the science community,” said Skovsø. By publishing a larger study, “we can spark even more conversation and understanding.”

The post Guest post: What does a cure for type 1 diabetes (T1D) look like? appeared first on Breakthrough T1D.

Do you prefer the sweetness of a Hershey’s kiss, or maybe you like the spice of a cinnamon heart? For most of us, we can grab a handful of Valentine’s Day candy without thinking about it. But for people living with type 1 diabetes (T1D) every snack, every meal, every piece of food eaten must first be calculated for carbs and sugar against the insulin they need to take – just to stay alive.

For newly diagnosed families, learning the calculations of carbs against insulin needs can be challenging at first, but with practice and consistency this should become easier over time. And even for people who have been living with T1D for decades, the sugar or carb counts of certain foods can vary, either by brand or a change to the product.

Always make sure to check the label carefully, and consider downloading an app, like Roche’s mySugr app, Diabetes M, or apps from your device manufacturers. Visit the website of the manufacturer of your device to find out more.

Carbs and Cals lets you take a photo of your meal, and the app searches its library of over 19,000 foods to give you the nutritional information you need.

MyFitnessPal app includes a database of over 14 million foods so you can find out nutritional information about what you’re eating, including the amount of carbs. It has a handy barcode scanner for ready-made products, and you can also add your own foods.

There is a free version and a paid version which has more features. The app is compatible with iOS and Android.

We always want the holidays to be fun for you, or a loved one with T1D, knowing that treats can still safely be enjoyed. It just requires a little extra work and knowing the carb levels of  favourite candies.

Remember also to factor in the portion of candy or chocolate you or your child eats to get a more accurate carb count.

• Great Value Cinnamon Hearts (25 pieces) contains 15g total carbs, 15g net carbs, 0g fat, 0g protein, and 60 calories.
• Hershey Kiss (1 piece) contains 3g total carbs, 2.8g net carbs, 1.5g fat, 0.4g protein, and 27 calories.
• Hershey’s Reese’s Peanut Butter Cup (1 package – each 1.5 OZ – 2 cups – 2 1/8″ diameter per cup) contains 23g total carbs, 21.7g net carbs, 12.8g fat, 4.3g protein, and 216 calories.
• Jellybeans (10 piece) contains 28g total carbs, 28g net carbs, 0g fat, 0g protein, and 113 calories
• Compliments Jujubes (8 candies) contains 33g total carbs, 33g net carbs, 0g fat, 0g protein, and 130 calories.

(values found at https://www.carbmanager.com/)

For a more detailed list of Valentine’s candies and their carb counts, thank you to our friends at Waltzing the Dragon for this Valentine Treat Carb Guide (https://waltzingthedragon.ca/diabetes/nutrition-excercise/valentines-day-candy-chocolate-carb-counting-tips/)

The post Valentine’s Day Treat Carb Counts appeared first on Breakthrough T1D.